Non-credit course introduces participants to the challenges facing the world at the intersection of biodefense and public health.Pandemics and bioterrorist attacks will also confront government agencies and the private sector with the need to make high-impact decisions with limited information during a rapidly evolving situation.
Research with dangerous pathogens and the development of dual-use biotechnologies poses a dilemma for policy-makers and researchers who seek to maximize the benefits of such research while minimizing the risks.
Thus, public health, law enforcement and national security agencies, pharmaceutical and biotech industries, and the academic life sciences community need to establish new priorities, such as developing new types of expertise, adopting new types of risk assessment and risk management strategies, and learning to collaborate with each other. Sponsor: George Mason University